1887

Abstract

To identify Mengo virus-specific T cell epitopes in mice (the natural host for the virus), lymph node cells were obtained from BALB/c () mice, previously immunized with u.v.-inactivated virus, and stimulated with each of 116 overlapping peptides (10 to 18 residues long) covering the entire capsid coding region (834 amino acids). T cell epitopes were defined on the basis of specific peptide-induced lymphocyte proliferation. Where proliferation occurred, immunological characterization showed that it was the CD4 T helper (T) cell subpopulation that was responsible for the Mengo virus-specific response. Surprisingly, no Mengo virus T cell epitopes were found in capsid protein VP1 or VP4. Six peptides in VP2 (residues 1 to 15, 99 to 108, 118 to 132, 133 to 147, 227 to 236 and 247 to 256) identified the positions of separate T cell epitopes, and two overlapping peptides (residues 173 to 182 and 178 to 192) defined an additional T cell immunogenic sequence. Three individual peptides in VP3 (residues 46 to 58, 136 to 150 and 198 to 212) and two overlapping peptides (residues 1 to 15 and 11 to 20) also represent T cell epitopes. Similar assays with C57BL/6 () and SJL/J () mice showed that the pattern of recognition of these peptides was H-2 restricted. Each of the previously identified sites of B cell antigenicity in VP2 and VP3 are associated with one T epitope. Comparison of the experimentally determined T epitopes with potential T cell epitopes identified by several predictive strategies revealed only a low correlation between authentic and predicted epitopes.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-75-11-2925
1994-11-01
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/75/11/JV0750112925.html?itemId=/content/journal/jgv/10.1099/0022-1317-75-11-2925&mimeType=html&fmt=ahah

References

  1. Baker P. J. 1993; Suppressor T cells. ASM News 59:123–128
    [Google Scholar]
  2. Boege U., Ko D. S. -W., Scraba D. G. 1986; Toward an in vitro system for picornavirus assembly; purification of Mengovirus 14S capsid precursor particles. Journal of Virology 57:275–284
    [Google Scholar]
  3. Boege U., Kobasa D., Onodera S., Parks G. D., Palmenberg A. C., Scraba D. G. 1991; Characterization of Mengo virus neutralization epitopes. Virology 181:1–13
    [Google Scholar]
  4. Brown J. H., Jardetzky T. S., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L., Wiley D. C. 1993; Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature; London: 36433–39
    [Google Scholar]
  5. Campbell J. B., Colter J. S. 1965; The pathogenicity to mice of three variants of Mengo encephalomyelitis virus. Journal of Cellular & Comparative Physiology 65:229–235
    [Google Scholar]
  6. Coffman R. L., Seynour B. W., Lebman D. A., Hiraki D. D., Christiansen J. A., Schrader B., Cherwinski H. M., Savelkoul H. M., Finkelman F. D., Bond M. W., Mosmann T. R. 1988; The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunology Reviews 102:5–28
    [Google Scholar]
  7. De Lisi C., Berzofsky J. A. 1985; T-cell antigenic sites tend to be amphipathic structures. Proceedings of the National Academy of Sciences U.S.A: 827048–7052
    [Google Scholar]
  8. Ellem K. A. O., Colter J. S. 1960; The interaction of infectious ribonucleic acid with a mammalian cell line. I. Relationship between the osmotic pressure of the medium and the production of infectious centers. Virology 11:434–443
    [Google Scholar]
  9. Ellem K. A. O., Colter J. S. 1961; The isolation of three variants of Mengo virus differing in plaque morphology and hemag-glutinating characteristics. Virology 15:340–347
    [Google Scholar]
  10. Feller D. C., De La Cruz V. F. 1991; Identifying antigenic T-cell sites. Nature; London: 349720–721
    [Google Scholar]
  11. Gammon G., Geysen H. M., Apple R. J., Pickett E., Palmer M., Ametani A., Sercarz E. E. 1991; T cell determinant structure: cores and determinant envelopes in three mouse major histocompatibility complex haplotypes. Journal of Experimental Medicine 173:609–617
    [Google Scholar]
  12. Graham S., Wang E. C. Y., Jenkins O., Borysiewicz K. L. 1993; Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. Journal of Virology 67:1627–1637
    [Google Scholar]
  13. Guthke R., Veckenstedt A., Guttner J., Stracke R., Bergter F. 1987; Dynamic model of the pathogenesis of Mengo virus infection in mice. Acta Virologica 31:307–320
    [Google Scholar]
  14. Hagenmaier H., Frank H. 1972; Increased coupling yields in solid phase peptide synthesis with a modified carbodiimide coupling procedure. Hoppe-Seyler’s Zeitschrift für Physiologische Chemie 353(S)1973–1976
    [Google Scholar]
  15. Hastings G. Z., Francis M. J., Rowlands D. J., Chain B. M. 1993; Epitope analysis of the T cell response to a complex antigen: proliferative rsponses to human rhinovirus capsids. European Journal of Immunology 23:2300–2305
    [Google Scholar]
  16. Houghten R. A. 1985; General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proceedings of the National Academy of Sciences U.S.A: 825131–5135
    [Google Scholar]
  17. Krishnaswamy S., Rossmann M. G. 1990; Structural refinement and analysis of Mengo virus. Journal of Molecular Biology 211:803–844
    [Google Scholar]
  18. Kutubuddin M., Simons J., Chow M. 1992; Identification of T-helper epitopes in the VP1 capsid protein of poliovirus. Journal of Virology 66:3042–3047
    [Google Scholar]
  19. Leclerc C., Deriaud E., Mimic V., Van Der Werf S. 1991; Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1. Journal of Virology 65:711–718
    [Google Scholar]
  20. Leclerc C., Deriaud E., Megret F., Briand J., Van Regenmortel M. H. V., Deubel V. 1993; Identification of helper T cell epitopes of Dengue virus E-protein. Molecular Immunology 30:613–625
    [Google Scholar]
  21. Luo M., Vriend G., Kamer G., Minor I., Arnold E. A., Rossmann M. G., Boege U., Scraba D. G., Duke G. M., Palmenberg A. C. 1987; The atomic structure of Mengovirus at 3.0 Å resolution. Science 235:182–191
    [Google Scholar]
  22. Mahon B. P., Katrak K., Mills K. H. G. 1992; Antigenic sequences of poliovirus recognized by T cells: serotype-specific epitopes on VP1 and VP3 and cross-reactive epitopes of VP4 defined by using CD4+ T-cell clones. Journal of Virology 66:7012–7020
    [Google Scholar]
  23. Margalit H., Spouge J. L., Cornette J. L., Cease K. B., Delisi C., Berzofsky J. A. 1987; Prediction of immunodominant helper T-cell antigenic site from the primary sequence. Journal of Immunology 138:2213–2229
    [Google Scholar]
  24. Merrifield R. B. 1963; Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society 85:2149–2154
    [Google Scholar]
  25. Mosmann T. R., Coffman R. L. 1989; Heterogeneity of cytokine secretion patterns and functions of helper T cells. Advances in Immunology 46:111–147
    [Google Scholar]
  26. Pallidino G., Scherle P. A., Gerhard W. 1991; Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza virus specific cytotoxic responses in vitro. Journal of Virology 65:6071–6076
    [Google Scholar]
  27. Panina-Bordignon P., Tan A., Termijtelen A., Demotz S., Corradin G., Lanzavecchia A. 1989; Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. European Journal of Immunology 19:2237–2242
    [Google Scholar]
  28. Partidos C., Stanley C., Steward M. 1992; The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides. European Journal of Immunology 22:2675–2680
    [Google Scholar]
  29. Patel V., Ferguson M., Minor P. D. 1992; Antigenic sites on type 2 poliovirus. Virology 192:361–364
    [Google Scholar]
  30. Raychaudhuri S., Morrow W. J. W. 1993; Can soluble antigens induce CD8+ cytotoxic T-cell responses? A paradox revisited. Immunology Today 14:344–348
    [Google Scholar]
  31. Rheinherz E. L., Schlossman S. F. 1981; The characterization and function of human immunoregulatory T lymphocytic subsets. Immunology Today 2:69–75
    [Google Scholar]
  32. Rothbard J. B., Taylor W. R. 1988; A sequence pattern common to T cell epitopes. EMBO Journal 7:93–100
    [Google Scholar]
  33. Scraba D. G. 1994; Cardioviruses. In Encyclopedia of Virology pp 205–213 Webster R. G., Granoff A. Edited by San Diego: Academic Press;
    [Google Scholar]
  34. Sette A., Buus S., Appella E., Smith J. A., Chestnut R., Miles C., Colon S. M., Grey H. M. 1989; Prediction of major histocompatibility complex binding regions of proteins antigens by sequence pattern analysis. Proceedings of the National Academy of Sciences U.S.A: 863296–3300
    [Google Scholar]
  35. Simons J., Kutubuddin M., Chow M. 1993; Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. Journal of Virology 67:1262–1268
    [Google Scholar]
  36. Stringfellow D. A., Overall J. C., Glasgow L. A. 1974; .Interferon inducers in therapy of infection with encephalocarditis virus in mice. Journal of Infectious Diseases 130:470–480
    [Google Scholar]
  37. Veckenstedt A. 1974; Pathogenicity of Mengo virus to mice. I.Virological Studies. Acta Virologica 18:501–507
    [Google Scholar]
  38. Veckenstedt A., Horn M. 1974; Testing of antiviral compounds against Mengo virus infection of mice. Experimental Chemotherapy 20:235–244
    [Google Scholar]
  39. Weigers K., Dernick R. 1992; Molecular basis of antigenic structures of poliovirus: implications for their evolution during morphogenesis. Journal of Virology 66:4597–4600
    [Google Scholar]
  40. Ziola B. R., Scraba D. G. 1974; Structure of the Mengo virion. I. Polypeptide and ribonucleate components of the virus particle. Virology 57:531–542
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-75-11-2925
Loading
/content/journal/jgv/10.1099/0022-1317-75-11-2925
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error